Regulatory/Legislation

2020 Presidential & Congressional Elections: Outcome and Agenda Outlook in the 117th Congress

November 21, 2020

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

How Real-World Data Is Impacting Health Care Decisions Today

October 25, 2020

By Mark Land, AAHP President I have been interested in the application of Real-World Data (RWD) and Real-World Evidence (RWE) for some time now. Originally, I confused RWD and RWE with Patient Centered Data (PCD). In doing so, I thought that patient-supplied evaluation, such as Quality of Life, Compliance, and Outcome assessments, might be of…

Homeopathic Process Validation for Beginners

October 25, 2020

Consistent, effective, high-quality homeopathic products. That’s what our consumers want in each and every dose. Yet quality doesn’t happen by accident. Manufacturers must create it through process validation. Each manufacturer must ask themselves: Do I have scientific evidence that my (manufacturing) process is capable of reliably delivering quality product?   It’s important to note that…

AAHP 2019: Reawakening the Regulatory and Retail Dialog

December 10, 2019

By Mark Land, AAHP President This year marks the fifth year in a cycle of regulatory review of homeopathic drug product labeling, safety, and quality. AAHP has been there for the industry as an advocate and representative over the entire duration. In 2019 AAHP provided direction and regulatory thought-leadership within the homeopathic community, met with…

Trump Nominates New FDA Commissioner

November 12, 2019

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

Why It’s Crucial to Monitor FDA Guidances

September 11, 2019

By Mark Land, AAHP President It can take several years for manufacturers to implement new guidelines from the Food and Drug Administration (FDA)—and that means they could be at risk in the meantime. However, manufacturers can “get ahead of the game” by monitoring FDA’s guidance development agenda. FDA’s authority to regulate stems from the Federal…

Australia to Release the First Draft Report on Homeopathy Effectiveness

September 10, 2019

By Mark Land, AAHP President   Many believe the draft report arrived at a more encouraging conclusion regarding the effectiveness of homeopathy and may have been suppressed by the then conservative Australian government. After years of requests and inquiry, Australia’s National Health and Medical Research Council (NHMRC) has decided to release the first draft report.…

2020 Democratic Presidential Run

August 2, 2019

By Pete Evich, AAHP Government Relations   As the 2020 U.S. presidential election inches closer, many Democratic hopefuls have launched campaigns to take the White House. At AAHP, we are keeping a close eye on the candidates and proposed policies that could affect the homeopathic industry. Here is an overview of key candidates and the…

summit photos

Summit Photos: Experience the Excitement

July 9, 2019

The AAHP community is still abuzz from all the excitement, networking, and learning that took place at last month’s Quality and Safety Summit in Baltimore! Between the opening reception and following day of sessions, we hosted more than 100 people from five countries across the globe. With a keynote session from Francis Godwin of the…

A First Look at AAHP Summit Speakers

May 14, 2019

We are thrilled to offer a first look at the speakers and sessions for our upcoming Summit on Challenges and Solutions in Quality & Safety of Homeopathic Drug Products! This unique one-day workshop is designed to help you manufacture safe products while complying within FDA and FTC guidelines. Some of the workshops included in the…

AAHP monitors and reports on current federal regulations, legislation and government policies that affect the homeopathic community. AAHP is often the first to learn of regulatory changes that have both direct and indirect effects on our industry enabling members to stay ahead of the curve in a rapidly changing healthcare environment.

Leave a Comment

You must be logged in to post a comment.